Zacks Research Issues Optimistic Outlook for PAHC Earnings

Phibro Animal Health Corporation (NASDAQ:PAHC) – Equities research analysts at Zacks Research upped their Q1 2026 earnings per share estimates for Phibro Animal Health in a report released on Tuesday, August 19th. Zacks Research analyst Team now expects that the company will post earnings of $0.33 per share for the quarter, up from their prior estimate of $0.32. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q2 2026 earnings at $0.60 EPS, Q3 2026 earnings at $0.61 EPS, FY2026 earnings at $2.21 EPS and FY2027 earnings at $2.35 EPS.

PAHC has been the topic of a number of other reports. Wall Street Zen raised Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. JPMorgan Chase & Co. raised Phibro Animal Health from a “neutral” rating to an “overweight” rating and lifted their price objective for the company from $25.00 to $35.00 in a report on Monday, July 7th. Morgan Stanley set a $26.00 price objective on Phibro Animal Health and gave the company an “equal weight” rating in a report on Wednesday, June 25th. BNP Paribas Exane raised Phibro Animal Health from an “underperform” rating to a “neutral” rating and set a $24.00 price objective on the stock in a report on Monday, June 16th. Finally, BNP Paribas raised Phibro Animal Health to a “hold” rating in a report on Monday, June 16th. One analyst has rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, Phibro Animal Health currently has an average rating of “Reduce” and a consensus price target of $24.40.

Phibro Animal Health Stock Down 2.2%

NASDAQ PAHC opened at $31.14 on Wednesday. The company has a current ratio of 2.91, a quick ratio of 1.23 and a debt-to-equity ratio of 2.67. The stock’s 50 day moving average is $28.00 and its two-hundred day moving average is $23.97. The company has a market capitalization of $1.26 billion, a price-to-earnings ratio of 39.92, a PEG ratio of 0.53 and a beta of 0.80. Phibro Animal Health has a 1-year low of $16.16 and a 1-year high of $32.08.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. Nuveen LLC bought a new position in Phibro Animal Health in the 1st quarter worth approximately $10,312,000. Invesco Ltd. raised its position in Phibro Animal Health by 92.3% in the 1st quarter. Invesco Ltd. now owns 387,739 shares of the company’s stock worth $8,282,000 after purchasing an additional 186,087 shares during the last quarter. Ranger Investment Management L.P. raised its position in Phibro Animal Health by 101.1% in the 2nd quarter. Ranger Investment Management L.P. now owns 357,970 shares of the company’s stock worth $9,143,000 after purchasing an additional 179,975 shares during the last quarter. Axecap Investments LLC bought a new position in Phibro Animal Health in the 1st quarter worth approximately $3,696,000. Finally, Millennium Management LLC raised its position in Phibro Animal Health by 74.3% in the 1st quarter. Millennium Management LLC now owns 362,030 shares of the company’s stock worth $7,733,000 after purchasing an additional 154,281 shares during the last quarter. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd will be paid a $0.12 dividend. The ex-dividend date is Wednesday, September 3rd. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.5%. Phibro Animal Health’s payout ratio is 61.54%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.